SequelSEC

ACCENDRA HEALTH INC/VA/ ACH

Wholesale-Medical, Dental & Hospital Equipment & Supplies · CIK 0000075252 · Fiscal year ends 1231

Revenue
$2.65B
Fiscal year ended 2026-06-30
Operating income
$29.35M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

ACCENDRA HEALTH INC/VA/ (ACH) reported revenue of $2.65B and net income of -$302.14M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from ACCENDRA HEALTH INC/VA/’s SEC filings, each linked to the filing it came from.

Income

ACCENDRA HEALTH INC/VA/ income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$2.65B
Cost of revenue$1.46B
Gross profit$1.19B
Operating income$29.35M
Net income-$302.14M
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax income-$115.48M
Income tax expense-$4.89M
Diluted EPSUnavailable
Selling, general & administrative$1.04B
General & administrativeUnavailable
Selling & marketingUnavailable

Balance

ACCENDRA HEALTH INC/VA/ balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$7.65M
Total assets$2.11B
Current assets$271.45M
Total liabilities$2.66B
Current liabilities$666.22M
Total equity incl. NCI-$550.94M
Temporary (mezzanine) equityUnavailable
Inventory$73.34M
Accounts receivableUnavailable
Goodwill$1.23B
Long-term debt$1.72B
Accounts payable$352.80M

Cash flow

ACCENDRA HEALTH INC/VA/ cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flowUnavailable
Capital expenditures$176.77M
Investing cash flow$268.22M
Financing cash flow-$157.29M
Net change in cash-$69.44M
Stock-based compensation$10.67M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$256.08M

Derived

ACCENDRA HEALTH INC/VA/ derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flowUnavailable
Gross margin44.8%
Operating margin1.1%
FCF marginUnavailable
SBC / revenue0.4%
Current ratio0.41x
Revenue YoY growth-3.3%
Net margin-11.4%
R&D / revenueUnavailable
CapEx / revenue6.7%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-20View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.